IL108681A0 - Influenza vaccine compositions - Google Patents

Influenza vaccine compositions

Info

Publication number: IL108681A0
Authority: IL; Israel
Prior art keywords: vaccine compositions; influenza vaccine; influenza; compositions; vaccine
Prior art date: 1993-02-19

Application number

IL10868194A

Other languages

English (en)

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-02-19

Filing date

1994-02-17

Publication date

1994-05-30

1994-02-17 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

1994-05-30 Publication of IL108681A0 publication Critical patent/IL108681A0/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Mycology (AREA)
Microbiology (AREA)
Virology (AREA)
Immunology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Dispersion Chemistry (AREA)
Pulmonology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

IL10868194A 1993-02-19 1994-02-17 Influenza vaccine compositions IL108681A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US2153593A	1993-02-19	1993-02-19
US11575093A	1993-09-01	1993-09-01

Publications (1)

Publication Number	Publication Date
IL108681A0 true IL108681A0 (en)	1994-05-30

Family

ID=26694802

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL10868194A IL108681A0 (en)	1993-02-19	1994-02-17	Influenza vaccine compositions

Country Status (9)

Country	Link
EP (1)	EP0684838A1 (fr)
AP (1)	AP431A (fr)
AU (1)	AU6141094A (fr)
CA (1)	CA2156525A1 (fr)
IL (1)	IL108681A0 (fr)
MA (1)	MA23118A1 (fr)
MX (1)	MX9401225A (fr)
SI (1)	SI9400085A (fr)
WO (1)	WO1994019013A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9105992D0 (en) *	1991-03-21	1991-05-08	Smithkline Beecham Biolog	Vaccine
EP0689454B2 (fr) *	1993-03-23	2005-02-23	SMITHKLINE BEECHAM BIOLOGICALS s.a.	Compositions vaccinales renfermant le lipide a monophosphorylique 3-o desacetyle
UA56132C2 (uk) *	1995-04-25	2003-05-15	Смітклайн Бічем Байолоджікалс С.А.	Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
US6306404B1 (en)	1998-07-14	2001-10-23	American Cyanamid Company	Adjuvant and vaccine compositions containing monophosphoryl lipid A
GB9820525D0 (en) *	1998-09-21	1998-11-11	Allergy Therapeutics Ltd	Formulation
US6261573B1 (en) *	1998-10-30	2001-07-17	Avant Immunotherapeutics, Inc.	Immunoadjuvants
AT407958B (de) *	1999-02-11	2001-07-25	Immuno Ag	Inaktivierte influenza-virus-vakzine zur nasalen oder oralen applikation
US6635261B2 (en)	1999-07-13	2003-10-21	Wyeth Holdings Corporation	Adjuvant and vaccine compositions containing monophosphoryl lipid A
GB9923176D0 (en) *	1999-09-30	1999-12-01	Smithkline Beecham Biolog	Novel composition
RU2164148C1 (ru) *	2000-08-09	2001-03-20	Петров Рэм Викторович	Вакцина против вируса гриппа и способ ее получения
AU2002254901A1 (en)	2001-02-23	2002-10-03	Smithkline Beecham Biologicals S.A.	Influenza vaccine formulations for intradermal delivery
AR032575A1 (es) *	2001-02-23	2003-11-12	Smithkline Beecham Biolog	Uso de una preparacion antigenica de gripe para la fabricacion de una vacuna intradermica de la gripe y estuche farmaceutico que comprende dicha vacuna
AU2002254558A1 (en) *	2001-04-27	2002-11-11	Becton, Dickinson And Company	Novel vaccine
JP2008512443A (ja)	2004-09-09	2008-04-24	カイロンベーリングゲーエムベーハーアンドカンパニー	インフルエンザワクチンに関連する潜在的医原性リスクの減少
AU2005314563B2 (en)	2004-11-03	2011-06-30	Seqirus UK Limited	Influenza vaccination
JP5770414B2 (ja)	2005-03-23	2015-08-26	グラクソスミスクラインバイオロジカルズソシエテアノニム	新規組成物
PL2043682T3 (pl)	2006-07-17	2014-09-30	Glaxosmithkline Biologicals Sa	Szczepionka przeciw grypie
BRPI0721393B8 (pt) *	2007-03-22	2022-09-06	Fund Butantan	método para obter lipídeo a monofosforilado da bordetella pertussis como um subproduto da produção de vacina celular contra coqueluche
TW200908994A (en)	2007-04-20	2009-03-01	Glaxosmithkline Biolog Sa	Vaccine
WO2009115917A2 (fr)	2008-03-18	2009-09-24	Novartis Ag	Améliorations dans la préparation des antigènes pour le vaccin contre le virus de la grippe
CA2812135A1 (fr)	2010-09-07	2012-03-15	Novartis Ag	Tests generiques pour la detection de reovirus de mammiferes
EP2653156A1 (fr) *	2012-10-01	2013-10-23	College of Pharmacy of Taif University	Composition d'émulsion pharmaceutique et son utilisation
RU2016141621A (ru) *	2014-03-25	2018-04-25	Зэ Гавермент Оф Зэ Юнайтед Стэйтс Оф Америка Эс Репрезентед Бай Зэ Секретари Оф Зэ Арми	Способы усиления эффективности иммуностимуляции адсорбированных на соли алюминия вакцин
AU2019302562A1 (en)	2018-07-10	2021-01-14	Seqirus Pty Ltd	Removal of agglomerates
CN112361796A (zh) *	2020-11-13	2021-02-12	安徽省天长市周氏羊业有限公司	一种秸秆回收储存前破碎干燥装置
CN114989269B (zh) *	2022-06-30	2023-09-19	天康制药股份有限公司	一种牛赤羽免疫原性抗原及疫苗

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5230899A (en) *	1985-08-07	1993-07-27	Smithkline Beecham Corporation	Methods and compositions for making liposomes
IL79114A (en) *	1985-08-07	1990-09-17	Allergan Pharma	Method and composition for making liposomes
US4912094B1 (en) *	1988-06-29	1994-02-15	Ribi Immunochem Research Inc.	Modified lipopolysaccharides and process of preparation
AU627226B2 (en) *	1988-08-25	1992-08-20	Liposome Company, Inc., The	Influenza vaccine and novel adjuvants
DK425789A (da) *	1988-08-31	1990-03-01	Smithkline Beecham Corp	Vaccinale polypeptider
AU640348B2 (en) *	1988-08-31	1993-08-26	Smithkline Beecham Corporation	Vaccinal Polypeptides
WO1992006113A2 (fr) *	1990-09-28	1992-04-16	Smithkline Beecham Biologicals (S.A.)	DERIVES DE gp160 ET VACCINS A BASE DE gp160 OU D'UN DE SES DERIVES, CONTENANT UN ADJUVANT
EP0563091A1 (fr) *	1990-12-20	1993-10-06	SMITHKLINE BEECHAM BIOLOGICALS s.a.	VACCINS A BASE DE l'ANTIGENE D'ENVELOPPE DU VIRUS DE L'HEPATITE B
FR2671974A1 (fr) *	1991-01-24	1992-07-31	Pasteur Merieux Serums Vacc	Composition vaccinale contre la grippe, a effet synergique, contenant comme additif du core de virus grippal.
GB9105992D0 (en) *	1991-03-21	1991-05-08	Smithkline Beecham Biolog	Vaccine
CA2138997C (fr) *	1992-06-25	2003-06-03	Jean-Paul Prieels	Composition vaccinale qui contient des adjuvants

1994
- 1994-02-15 WO PCT/EP1994/000448 patent/WO1994019013A1/fr not_active Application Discontinuation
- 1994-02-15 CA CA002156525A patent/CA2156525A1/fr not_active Abandoned
- 1994-02-15 AU AU61410/94A patent/AU6141094A/en not_active Abandoned
- 1994-02-15 EP EP94908327A patent/EP0684838A1/fr not_active Withdrawn
- 1994-02-17 IL IL10868194A patent/IL108681A0/xx unknown
- 1994-02-17 MX MX9401225A patent/MX9401225A/es unknown
- 1994-02-17 MA MA23425A patent/MA23118A1/fr unknown
- 1994-02-17 AP APAP/P/1994/000621A patent/AP431A/en active
- 1994-02-18 SI SI9400085A patent/SI9400085A/sl unknown

Also Published As

Publication number	Publication date
AP431A (en)	1995-11-15
CA2156525A1 (fr)	1994-09-01
MX9401225A (es)	1994-08-31
EP0684838A1 (fr)	1995-12-06
WO1994019013A1 (fr)	1994-09-01
SI9400085A (en)	1994-09-30
AU6141094A (en)	1994-09-14
AP9400621A0 (en)	1994-04-30
MA23118A1 (fr)	1994-10-01

Publication	Publication Date	Title
IL109056A0 (en)	1994-06-24	Vaccine compositions
IL108681A0 (en)	1994-05-30	Influenza vaccine compositions
AP9300502A0 (en)	1993-04-30	Vaccine compositions
IL118004A0 (en)	1996-08-04	Vaccine compositions
ZA961460B (en)	1996-08-29	Vaccine compositions
AU1308495A (en)	1995-08-01	Influenza vaccine
IL108915A0 (en)	1994-06-24	Polynucleotide vaccine against influenza virus
GR3034798T3 (en)	2001-02-28	Influenza vaccine
ZA946262B (en)	1995-03-20	Pharmaceutical compositions
IL128318A0 (en)	2000-01-31	Vaccine composition against malaria
GB9401787D0 (en)	1994-03-23	Vaccine compositions
IL110201A0 (en)	1994-10-21	Novel pharmaceutical compositions
GB9317610D0 (en)	1993-10-06	Pharmaceutical compositions
GB9326425D0 (en)	1994-02-23	Vaccine compositions
GB9317504D0 (en)	1993-10-06	Pharmaceutical compositions
GB9614618D0 (en)	1996-09-04	Vaccine compositions
HU9401771D0 (en)	1994-09-28	Pharmaceutical compositions cintaining ipsapiron
ZA941957B (en)	1995-01-31	Vaccine compositions
GB9320454D0 (en)	1993-11-24	Vaccine compositions
GB9601739D0 (en)	1996-03-27	Vaccine Compositions
GB9416097D0 (en)	1994-09-28	Vaccine compositions
GB9403417D0 (en)	1994-04-13	Vaccine compositions
GB9425980D0 (en)	1995-02-22	Vaccine compositions
ZA949128B (en)	1995-11-10	Vaccine
ZA947878B (en)	1996-04-09	Pharmaceutical compositions